Boehringer Ingelheim

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organization, the Board of Managing Directors and the company’s history as well as our engagement for scientific, cultural and environmental purposes.

History

The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein. From its beginnings in 1885 when it employed just 28 people in Nieder-Ingelheim, the company has since become a global enterprise.

As part of research and development activities for innovative drugs, the company focuses primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.

The Making More Health Initiative (MMH)

“Making more health” is a long-term initiative with the goal to improve health in communities around the world by identifying and supporting the most promising solutions to challenging health problems. Since 2010, Boehringer Ingelheim and the non-governmental organisation Ashoka are working together in a global partnership. Together with our partner Ashoka we engage actively in single social entrepreneurship projects. Ashoka displays competence in creating change and comes with the network and know-how to identify and to advance social innovators. Boehringer Ingelheim is competent in the healthcare and business sectors. We can provide the social entrepreneurs with a great deal of experience in professional project management. Furthermore, we support the entrepreneurs with our skills, experience, and network. This way of collaboration forms a win-win situation for everyone: For our fellows, for Ashoka and Boehringer Ingelheim.